MBS303-B-AX-0RAA Vitrohm | Mouser Europe - Mouser

mbs303 MBS303 is a CD20×CD3 T-cell-engaging bispecific antibody that has a novel 2:1 (CD20:CD3) confuration to kill malnant B cells. This dose-escalation phase Ⅰ trial evaluated the safety. MBS-303: CD20CD3Beijing Mabworks Biotech Co., Ltd. ()12

mbs303, MBS303MSC303 (MBS303 as the intravenous formulation, MSC303 as the subcutaneous formulation) is an innovative CD20CD3 T-cell engager. MBS303 has initiated clinical trials.